MedPath

Zoledronic Acid

These highlights do not include all the information needed to use ZOLEDRONIC ACID INJECTION  safely and effectively. See full prescribing information for ZOLEDRONIC ACID INJECTION. ZOLEDRONIC ACID injection Initial U.S. Approval: 2001

Approved
Approval ID

824eaeee-6b3d-4d62-b268-77f8bd8e7f10

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 8, 2020

Manufacturers
FDA

Gland Pharma Limited

DUNS: 918601238

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Zoledronic Acid

PRODUCT DETAILS

NDC Product Code68083-135
Application NumberANDA204217
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateAugust 8, 2020
Generic NameZoledronic Acid

INGREDIENTS (3)

MannitolInactive
Code: 3OWL53L36A
Classification: IACT
Zoledronic AcidActive
Quantity: 5 mg in 100 mL
Code: 6XC1PAD3KF
Classification: ACTIM
Sodium CitrateInactive
Code: 1Q73Q2JULR
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zoledronic Acid - FDA Drug Approval Details